AG真人官方

STOCK TITAN

[8-K] Surgery Partners, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Surgery Partners, Inc. (Nasdaq: SGRY) filed a Form 8-K dated 5 Aug 2025. Under Item 2.02, the Company states it has furnished鈥攏ot filed鈥攁 press release (Exhibit 99.1) that outlines results for the three- and six-month periods ended 30 Jun 2025. No numerical performance data are included in the 8-K itself. The filing notes that any non-GAAP measures discussed in the release are reconciled to the most comparable GAAP figures within that exhibit. Pursuant to General Instruction B.2, the furnished information is not subject to Section 18 liability and is not incorporated by reference into other SEC filings. Exhibit 104 provides the Inline XBRL cover page tag set.

Surgery Partners, Inc. (Nasdaq: SGRY) ha presentato un Modulo 8-K datato 5 agosto 2025. Ai sensi del Punto 2.02, la Societ脿 dichiara di aver fornito鈥攅 non depositato鈥攗n comunicato stampa (Esibizione 99.1) che illustra i risultati relativi ai periodi di tre e sei mesi terminati il 30 giugno 2025. Nel modulo 8-K non sono inclusi dati numerici sulle performance. La documentazione specifica che eventuali misure non GAAP discusse nel comunicato sono riconciliate con le corrispondenti cifre GAAP pi霉 comparabili all'interno di tale esibizione. In conformit脿 alle Istruzioni Generali B.2, le informazioni fornite non sono soggette alla responsabilit脿 ai sensi della Sezione 18 e non sono incorporate per riferimento in altri documenti SEC. L'Esibizione 104 contiene il set di tag Inline XBRL per la pagina di copertina.

Surgery Partners, Inc. (Nasdaq: SGRY) present贸 un Formulario 8-K con fecha 5 de agosto de 2025. Bajo el Punto 2.02, la Compa帽铆a indica que ha proporcionado鈥攏o presentado鈥攗n comunicado de prensa (Exhibici贸n 99.1) que detalla los resultados de los per铆odos de tres y seis meses finalizados el 30 de junio de 2025. No se incluyen datos num茅ricos de desempe帽o en el propio 8-K. El documento se帽ala que cualquier medida no GAAP mencionada en el comunicado se reconcilia con las cifras GAAP m谩s comparables dentro de esa exhibici贸n. Conforme a la Instrucci贸n General B.2, la informaci贸n proporcionada no est谩 sujeta a la responsabilidad de la Secci贸n 18 y no se incorpora por referencia en otros archivos ante la SEC. La Exhibici贸n 104 contiene el conjunto de etiquetas Inline XBRL para la portada.

Surgery Partners, Inc. (Nasdaq: SGRY)電� 2025雲� 8鞗� 5鞚检瀽 Form 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 頃 2.02鞐� 霐半澕 須岇偓電� 2025雲� 6鞗� 30鞚� 膦呺霅� 3臧滌洈 氚� 6臧滌洈 旮瓣皠鞚� 鞁れ爜鞚� 鞖旍暯頃� 氤措弰鞛愲(鞝勳嫓氍� 99.1)毳� 鞝滌稖頃� 瓴冹澊 鞎勲媹霛� 鞝滉车頄堧嫟瓿� 氇呾嫓頄堨姷雼堧嫟. 8-K 鞛愳泊鞐愲姅 靾橃箻 靹标臣 雿办澊韯瓣皜 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟. 鞝滌稖 氍胳劀鞐愲姅 氤措弰鞛愲鞐愳劀 雲检潣霅� 牍�-GAAP 歆響滉皜 頃措嫻 鞝勳嫓氍� 雮挫棎靹� 臧鞛� 鞙犾偓頃� GAAP 靾橃箻鞕 臁办爼霅橃柎 鞛堨潓鞚� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 鞚茧皹 歆旃� B.2鞐� 霐半澕 鞝滉车霅� 鞝曤炒電� 靹轨厴 18 毂呾瀯 雽靸侅澊 鞎勲媹氅� 雼るジ SEC 鞝滌稖 氍胳劀鞐� 彀胳“搿� 韽暔霅橃 鞎婌姷雼堧嫟. 鞝勳嫓氍� 104電� 鞚鸽澕鞚� XBRL 響滌 韮滉犯 靹疙姼毳� 鞝滉车頃╇媹雼�.

Surgery Partners, Inc. (Nasdaq : SGRY) a d茅pos茅 un formulaire 8-K dat茅 du 5 ao没t 2025. En vertu du point 2.02, la Soci茅t茅 d茅clare avoir fourni鈥攅t non d茅pos茅鈥攗n communiqu茅 de presse (Exhibit 99.1) qui pr茅sente les r茅sultats des p茅riodes de trois et six mois termin茅es au 30 juin 2025. Aucun chiffre de performance n鈥檈st inclus dans le 8-K lui-m锚me. Le d茅p么t pr茅cise que toute mesure non-GAAP mentionn茅e dans le communiqu茅 est rapproch茅e des chiffres GAAP les plus comparables au sein de cette annexe. Conform茅ment 脿 l鈥橧nstruction G茅n茅rale B.2, les informations fournies ne sont pas soumises 脿 la responsabilit茅 en vertu de la Section 18 et ne sont pas incorpor茅es par r茅f茅rence dans d鈥檃utres d茅p么ts aupr猫s de la SEC. L鈥橢xhibit 104 fournit l鈥檈nsemble des balises Inline XBRL pour la page de couverture.

Surgery Partners, Inc. (Nasdaq: SGRY) reichte am 5. August 2025 ein Formular 8-K ein. Unter Punkt 2.02 gibt das Unternehmen an, eine Pressemitteilung (Anlage 99.1), die die Ergebnisse der drei- und sechsmonatigen Perioden zum 30. Juni 2025 darlegt, bereitgestellt鈥攏icht eingereicht鈥攝u haben. Im 8-K selbst sind keine numerischen Leistungsdaten enthalten. Die Einreichung weist darauf hin, dass alle in der Pressemitteilung besprochenen Non-GAAP-Kennzahlen in der Anlage mit den am besten vergleichbaren GAAP-Zahlen abgeglichen werden. Gem盲脽 der Allgemeinen Anweisung B.2 unterliegt die bereitgestellte Information nicht der Haftung gem盲脽 Abschnitt 18 und wird nicht durch Verweis in andere SEC-Einreichungen aufgenommen. Anlage 104 enth盲lt das Inline-XBRL-Titelseiten-Tag-Set.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine 8-K furnishing Q2-25 earnings press release; no figures disclosed; neutral investment impact.

The filing merely alerts investors that the Company has released its second-quarter 2025 results via a separate press release. Because the 8-K carries no financial metrics, it does not, by itself, change the investment thesis. The use of Item 2.02 and the 鈥渇urnished, not filed鈥� language shields the disclosures from Section 18 liability, following standard practice for earnings releases. Investors must consult Exhibit 99.1 for revenue, EPS, margin trends or guidance data before making any assessment. Overall impact is neutral until those numbers are reviewed.

Surgery Partners, Inc. (Nasdaq: SGRY) ha presentato un Modulo 8-K datato 5 agosto 2025. Ai sensi del Punto 2.02, la Societ脿 dichiara di aver fornito鈥攅 non depositato鈥攗n comunicato stampa (Esibizione 99.1) che illustra i risultati relativi ai periodi di tre e sei mesi terminati il 30 giugno 2025. Nel modulo 8-K non sono inclusi dati numerici sulle performance. La documentazione specifica che eventuali misure non GAAP discusse nel comunicato sono riconciliate con le corrispondenti cifre GAAP pi霉 comparabili all'interno di tale esibizione. In conformit脿 alle Istruzioni Generali B.2, le informazioni fornite non sono soggette alla responsabilit脿 ai sensi della Sezione 18 e non sono incorporate per riferimento in altri documenti SEC. L'Esibizione 104 contiene il set di tag Inline XBRL per la pagina di copertina.

Surgery Partners, Inc. (Nasdaq: SGRY) present贸 un Formulario 8-K con fecha 5 de agosto de 2025. Bajo el Punto 2.02, la Compa帽铆a indica que ha proporcionado鈥攏o presentado鈥攗n comunicado de prensa (Exhibici贸n 99.1) que detalla los resultados de los per铆odos de tres y seis meses finalizados el 30 de junio de 2025. No se incluyen datos num茅ricos de desempe帽o en el propio 8-K. El documento se帽ala que cualquier medida no GAAP mencionada en el comunicado se reconcilia con las cifras GAAP m谩s comparables dentro de esa exhibici贸n. Conforme a la Instrucci贸n General B.2, la informaci贸n proporcionada no est谩 sujeta a la responsabilidad de la Secci贸n 18 y no se incorpora por referencia en otros archivos ante la SEC. La Exhibici贸n 104 contiene el conjunto de etiquetas Inline XBRL para la portada.

Surgery Partners, Inc. (Nasdaq: SGRY)電� 2025雲� 8鞗� 5鞚检瀽 Form 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 頃 2.02鞐� 霐半澕 須岇偓電� 2025雲� 6鞗� 30鞚� 膦呺霅� 3臧滌洈 氚� 6臧滌洈 旮瓣皠鞚� 鞁れ爜鞚� 鞖旍暯頃� 氤措弰鞛愲(鞝勳嫓氍� 99.1)毳� 鞝滌稖頃� 瓴冹澊 鞎勲媹霛� 鞝滉车頄堧嫟瓿� 氇呾嫓頄堨姷雼堧嫟. 8-K 鞛愳泊鞐愲姅 靾橃箻 靹标臣 雿办澊韯瓣皜 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟. 鞝滌稖 氍胳劀鞐愲姅 氤措弰鞛愲鞐愳劀 雲检潣霅� 牍�-GAAP 歆響滉皜 頃措嫻 鞝勳嫓氍� 雮挫棎靹� 臧鞛� 鞙犾偓頃� GAAP 靾橃箻鞕 臁办爼霅橃柎 鞛堨潓鞚� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 鞚茧皹 歆旃� B.2鞐� 霐半澕 鞝滉车霅� 鞝曤炒電� 靹轨厴 18 毂呾瀯 雽靸侅澊 鞎勲媹氅� 雼るジ SEC 鞝滌稖 氍胳劀鞐� 彀胳“搿� 韽暔霅橃 鞎婌姷雼堧嫟. 鞝勳嫓氍� 104電� 鞚鸽澕鞚� XBRL 響滌 韮滉犯 靹疙姼毳� 鞝滉车頃╇媹雼�.

Surgery Partners, Inc. (Nasdaq : SGRY) a d茅pos茅 un formulaire 8-K dat茅 du 5 ao没t 2025. En vertu du point 2.02, la Soci茅t茅 d茅clare avoir fourni鈥攅t non d茅pos茅鈥攗n communiqu茅 de presse (Exhibit 99.1) qui pr茅sente les r茅sultats des p茅riodes de trois et six mois termin茅es au 30 juin 2025. Aucun chiffre de performance n鈥檈st inclus dans le 8-K lui-m锚me. Le d茅p么t pr茅cise que toute mesure non-GAAP mentionn茅e dans le communiqu茅 est rapproch茅e des chiffres GAAP les plus comparables au sein de cette annexe. Conform茅ment 脿 l鈥橧nstruction G茅n茅rale B.2, les informations fournies ne sont pas soumises 脿 la responsabilit茅 en vertu de la Section 18 et ne sont pas incorpor茅es par r茅f茅rence dans d鈥檃utres d茅p么ts aupr猫s de la SEC. L鈥橢xhibit 104 fournit l鈥檈nsemble des balises Inline XBRL pour la page de couverture.

Surgery Partners, Inc. (Nasdaq: SGRY) reichte am 5. August 2025 ein Formular 8-K ein. Unter Punkt 2.02 gibt das Unternehmen an, eine Pressemitteilung (Anlage 99.1), die die Ergebnisse der drei- und sechsmonatigen Perioden zum 30. Juni 2025 darlegt, bereitgestellt鈥攏icht eingereicht鈥攝u haben. Im 8-K selbst sind keine numerischen Leistungsdaten enthalten. Die Einreichung weist darauf hin, dass alle in der Pressemitteilung besprochenen Non-GAAP-Kennzahlen in der Anlage mit den am besten vergleichbaren GAAP-Zahlen abgeglichen werden. Gem盲脽 der Allgemeinen Anweisung B.2 unterliegt die bereitgestellte Information nicht der Haftung gem盲脽 Abschnitt 18 und wird nicht durch Verweis in andere SEC-Einreichungen aufgenommen. Anlage 104 enth盲lt das Inline-XBRL-Titelseiten-Tag-Set.

0001638833FALSE00016388332025-08-052025-08-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2025
Surgery Partners, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware001-3757647-3620923
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
340 Seven Springs Way, Suite 600
Brentwood, Tennessee 37027
(Address of Principal Executive Offices) (Zip Code)
(615) 234-5900
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareSGRYThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02 Results of Operations and Financial Condition.
On August 5, 2025, Surgery Partners, Inc. issued a press release announcing results for the three and six months ended June 30, 2025. See the press release attached as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
Surgery Partners makes reference to non-GAAP financial measures in the attached press release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP financial measures is provided therein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
99.1
Press release dated August 5, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SURGERY PARTNERS, INC.
Date:
August 5, 2025By:/s/ David T. Doherty
David T. Doherty
Executive Vice President and Chief Financial Officer


FAQ

When did Surgery Partners (SGRY) file this 8-K?

August 5, 2025.

What event is disclosed in the 8-K?

The company furnished a press release announcing results for the quarter and six months ended June 30 2025.

Which exhibit contains the earnings press release?

Exhibit 99.1 holds the full press release dated August 5 2025.

Does the 8-K include GAAP or non-GAAP numbers?

No, the filing itself contains no financial figures; reconciliations are within the press release.

What item of the Exchange Act does this filing address?

It pertains to Item 2.02 鈥� Results of Operations and Financial Condition.
Surgery Partners Inc

NASDAQ:SGRY

SGRY Rankings

SGRY Latest News

SGRY Latest SEC Filings

SGRY Stock Data

2.87B
76.28M
1.51%
111.57%
9.24%
Medical Care Facilities
Services-general Medical & Surgical Hospitals, Nec
United States
BRENTWOOD